iCeutica raises $1.1M for reformulated drugs
iCeutica, a Philadelphia biotech looking to “repackage” drugs in nanotechnology formulations that may improve their safety or effectiveness, raised $1.1 million in a second funding round, VentureWire reports (subscription required). Nordic Biotech and individual investors provided the funding.
Next Story: Plexus Biomed pulls in $2M for hemorrhoid relief
Previous Story: Ultrasounder SonoSite acquires LumenVu for catheter placement
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
